Latest Insider Transactions at Pmv Pharmaceuticals, Inc. (PMVP)
This section provides a real-time view of insider transactions for Pmv Pharmaceuticals, Inc. (PMVP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PMV Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PMV Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 23
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
23,838
-0.73%
|
$715,140
$30.86 P/Share
|
|
Aug 23
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.84%
|
$101,500
$29.5 P/Share
|
|
Aug 19
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+43.1%
|
$15,000
$3.22 P/Share
|
|
Aug 19
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+23.43%
|
$0
$0.53 P/Share
|
|
Aug 19
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
3,800
-0.23%
|
$114,000
$30.97 P/Share
|
|
Aug 18
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
26,864
-0.54%
|
$886,512
$33.58 P/Share
|
|
Aug 17
2021
|
Deepika Jalota Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,896
-100.0%
|
$95,568
$33.78 P/Share
|
|
Aug 17
2021
|
Deepika Jalota Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,896
+50.0%
|
$8,688
$3.53 P/Share
|
|
Aug 17
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
31,022
-0.92%
|
$1,023,726
$33.57 P/Share
|
|
Aug 16
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
22,183
-0.65%
|
$754,222
$34.17 P/Share
|
|
Aug 13
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
27,286
-0.78%
|
$927,724
$34.44 P/Share
|
|
Aug 12
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
13,536
-0.38%
|
$460,224
$34.59 P/Share
|
|
Aug 11
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
34,439
-1.92%
|
$1,170,926
$34.04 P/Share
|
|
Aug 10
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
20,505
-0.56%
|
$717,675
$35.15 P/Share
|
|
Aug 09
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,471
-81.7%
|
$152,014
$34.8 P/Share
|
|
Aug 09
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
Aug 09
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
22,182
-0.4%
|
$776,370
$35.95 P/Share
|
|
Aug 06
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
19,900
-0.54%
|
$716,400
$36.78 P/Share
|
|
Aug 05
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
35,611
-0.94%
|
$1,281,996
$36.54 P/Share
|
|
Aug 04
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
52,860
-0.68%
|
$1,850,100
$35.58 P/Share
|
|
Aug 03
2021
|
Winston Kung COO, CFO |
SELL
Open market or private sale
|
Direct |
4,500
-73.77%
|
$148,500
$33.82 P/Share
|
|
Aug 03
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.45%
|
$13,500
$3.22 P/Share
|
|
Aug 03
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
30,245
-0.76%
|
$1,028,330
$34.27 P/Share
|
|
Aug 02
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
13,031
-0.65%
|
$443,054
$34.74 P/Share
|
|
Jul 29
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
2,300
-0.12%
|
$80,500
$35.73 P/Share
|
|
Jul 28
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
8,724
-0.44%
|
$305,340
$35.76 P/Share
|
|
Jul 27
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
535
-0.03%
|
$18,725
$35.61 P/Share
|
|
Jul 26
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
4,839
-0.24%
|
$169,365
$35.73 P/Share
|
|
Jul 23
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
11,988
-0.59%
|
$431,568
$36.0 P/Share
|
|
Jul 22
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
200
-0.01%
|
$7,000
$35.61 P/Share
|
|
Jul 21
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
18,672
-0.92%
|
$653,520
$35.82 P/Share
|
|
Jul 21
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
26,767
-68.22%
|
$936,845
$35.76 P/Share
|
|
Jul 21
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,767
+40.55%
|
$0
$0.53 P/Share
|
|
Jul 20
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
1,029
-7.62%
|
$36,015
$35.53 P/Share
|
|
Jul 20
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,029
+7.08%
|
$0
$0.53 P/Share
|
|
Jul 20
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.83%
|
$122,500
$35.12 P/Share
|
|
Jul 13
2021
|
Interwest Partners X LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
125,863
+47.33%
|
-
|
|
Jul 13
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
97,632
-100.0%
|
-
|
|
Jul 13
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
500,000
-10.06%
|
-
|
|
Jul 08
2021
|
Winston Kung COO, CFO |
SELL
Open market or private sale
|
Direct |
4,500
-73.77%
|
$148,500
$33.75 P/Share
|
|
Jul 08
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.45%
|
$13,500
$3.22 P/Share
|
|
Jul 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-74.39%
|
$128,000
$32.3 P/Share
|
|
Jul 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
Jun 28
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
204
-1.61%
|
$7,140
$35.53 P/Share
|
|
Jun 28
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
204
+1.58%
|
$0
$0.53 P/Share
|
|
Jun 21
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.41%
|
$115,500
$33.66 P/Share
|
|
Jun 14
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
44,419
-0.98%
|
$1,510,246
$34.11 P/Share
|
|
Jun 11
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,977
-0.48%
|
$725,241
$33.8 P/Share
|
|
Jun 10
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,633
-0.45%
|
$660,256
$32.68 P/Share
|
|
Jun 09
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
39,638
-0.86%
|
$1,308,054
$33.64 P/Share
|